美国 · SEC FORM 4
XOMA Royalty Corp
XOMA · — · CIK 0000791908 · Healthcare
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
37 同一窗口内观察到的 Form 4 交易行
0 sales · 37 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-12-04 · Hughes Owen · $2.5M
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
LIMBER JOSEPH MDirector
○○○○
Hernday NatashaDirector
○○○
Sitko BradleyChief Investment Officer
○○○
BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK NOther; TenPercentOwner
○○
Kosacz BarbaraDirector
○○
Hughes OwenChief Executive Officer
○○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-12-04 · Hughes Owen.
近期 Form 4 活动
1买入
0卖出
50其他 Form 4 交易行
30SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他37 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-12-04 | Hughes Owen | 买入 (P) | Depositary Shares - 8.375% B Cumulative Stock | 100,000 | USD 25.05 | USD 2,505,000 | SEC 申报 ↗ |
| 2025-06-30 | Sitko Bradley | 买入 (P) | Depositary Shares - 8.375% Series B Cumulative Stock | 2,000 | USD 25.39 | USD 50,780 | SEC 申报 ↗ |
| 2025-04-07 | Sitko Bradley | 买入 (P) | Depositary Shares - 8.375% Series B Cumulative Stock | 2,000 | USD 24.70 | USD 49,400 | SEC 申报 ↗ |
| 2025-04-07 | LIMBER JOSEPH M | 买入 (P) | 8.625% Series A Cumulative Perpetual Preferred Stock | 5,243 | USD 25.60 | USD 134,221 | SEC 申报 ↗ |
| 2025-04-04 | LIMBER JOSEPH M | 买入 (P) | Depositary Shares - 8.375% Series B Cumulative Stock | 3,476 | USD 25.25 | USD 87,769 | SEC 申报 ↗ |
| 2025-04-04 | LIMBER JOSEPH M | 买入 (P) | 8.625% Series A Cumulative Perpetual Preferred Stock | 3,346 | USD 25.56 | USD 85,524 | SEC 申报 ↗ |
| 2025-04-03 | LIMBER JOSEPH M | 买入 (P) | Depositary Shares - 8.375% Series B Cumulative Stock | 16,524 | USD 25.22 | USD 416,735 | SEC 申报 ↗ |
| 2025-04-03 | LIMBER JOSEPH M | 买入 (P) | 8.625% Series A Cumulative Perpetual Preferred Stock | 1,411 | USD 25.44 | USD 35,896 | SEC 申报 ↗ |
| 2025-04-01 | BURNS THOMAS M. | 买入 (P) | Depositary Shares - 8.375% B Cumulative Stock | 1,000 | USD 25.46 | USD 25,460 | SEC 申报 ↗ |
| 2025-03-31 | Sitko Bradley | 买入 (P) | Depositary Shares - 8.375% Series B Perpetual Preferred | 245 | USD 25.39 | USD 6,221 | SEC 申报 ↗ |
| 2025-03-31 | Sitko Bradley | 买入 (P) | Common Stock | 1,000 | USD 19.98 | USD 19,980 | SEC 申报 ↗ |
| 2025-03-21 | Sitko Bradley | 买入 (P) | Depositary Shares - 8.375% B Cumulative Stock | 2,800 | USD 25.43 | USD 71,204 | SEC 申报 ↗ |
| 2025-03-21 | Sitko Bradley | 买入 (P) | Common Stock | 1,334 | USD 20.65 | USD 27,547 | SEC 申报 ↗ |
| 2025-01-08 | Sitko Bradley | 买入 (P) | Common Stock | 150 | USD 25.75 | USD 3,862 | SEC 申报 ↗ |
| 2025-01-08 | Sitko Bradley | 买入 (P) | 8.625% Series A Cumulative Perpetual Preferred Stock | 395 | USD 25.60 | USD 10,112 | SEC 申报 ↗ |
Form 4 申报证据
51 transaction lines in the latest 365-day window; 222 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-14 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | U (U) | Common Stock, $0.0075 par value per share | 7,593,303 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | WYSZOMIERSKI JACK L | J (J) | Common Stock | 21,828 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Trigilio Jeffrey | J (J) | Common Stock | 103,906 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-14 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | U (U) | Common Stock, $0.0075 par value per share | 7,593,303 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | WYSZOMIERSKI JACK L | J (J) | Common Stock | 21,828 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Trigilio Jeffrey | J (J) | Common Stock | 103,906 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Sitko Bradley | J (J) | Common Stock | 86,627 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Sitko Bradley | D (D) | Depositary Shares - 8.375% Series B Cumulative Stock | 9,045 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Sitko Bradley | D (D) | 8.625% Series A Cumulative Perpetual Preferred Stock | 395 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | PERRY MATTHEW D | J (J) | Common Stock | 24,138 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Montano Maricel Perea | J (J) | Common Stock | 42,371 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | LIMBER JOSEPH M | J (J) | Common Stock | 9,532 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | LIMBER JOSEPH M | D (D) | Depositary Shares - 8.375% Series B Cumulative Stock | 20,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | LIMBER JOSEPH M | D (D) | 8.625% Series A Cumulative Perpetual Preferred Stock | 10,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Kosacz Barbara | J (J) | Common Stock | 6,269 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Hughes Owen | J (J) | Common Stock | 192,016 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Hughes Owen | D (D) | Depositary Shares - 8.375% Series B Cumulative Stock | 102,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Hernday Natasha | J (J) | Common Stock | 9,304 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Hernday Natasha | D (D) | 8.625% Series A Cumulative Perpetual Preferred Stock | 4,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-14 | Franklin Heather L | J (J) | Common Stock | 6,269 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-21 | WYSZOMIERSKI JACK L | 奖励／授予 (A) | Common Stock | 3,586 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | PERRY MATTHEW D | 奖励／授予 (A) | Common Stock | 3,586 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | LIMBER JOSEPH M | 奖励／授予 (A) | Common Stock | 3,586 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Kosacz Barbara | 奖励／授予 (A) | Common Stock | 3,586 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Hernday Natasha | 奖励／授予 (A) | Common Stock | 3,586 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Franklin Heather L | 奖励／授予 (A) | Common Stock | 3,586 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | C (C) | Common Stock, $0.0075 par value per share | 5,003,000 | USD 4.03 | USD 20,162,090 | SEC 申报 ↗ |
| 2026-04-20 | Trigilio Jeffrey | 期权行权／转换 (M) | Common Stock | 11,538 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-20 | Sitko Bradley | 期权行权／转换 (M) | Common Stock | 3,737 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-20 | Montano Maricel Perea | 期权行权／转换 (M) | Common Stock | 3,370 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-20 | Hughes Owen | 期权行权／转换 (M) | Common Stock | 10,568 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-13 | Trigilio Jeffrey | 期权行权／转换 (M) | Common Stock | 4,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-13 | Trigilio Jeffrey | 代扣税 (F) | Common Stock | 1,632 | USD 36.76 | USD 59,992 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | XOMA |
| CIK | 0000791908 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | — |
数据覆盖
| 本地 Form 4 历史 | 222 transaction lines from 2020-03-13 to 2026-07-14 85 P purchase lines · 44 S sale lines · 93 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.